DGX - הכנסה תפעולית לפני ניכוי פחת Quest Diagnostics Incorporated

Quest Diagnostics conservative management is effectively optimizing costs and expanding diagnostics, as illustrated by the EBITDA_Co chart. The value 2313.10 serves as the parameter's baseline, helping to avoid purchasing the asset at its peak. Logistics and IT support have been outsourced to external partners, while a closed ecosystem with high clinic loyalty offsets regulatory pressure regarding Medicare tariffs.

This metric measures operating profit before interest and taxes, reflecting the net cash flow from core operations. The trend of this metric confirms financial stability and the business's ability to act as a cash generator. Analyzing changes in EBITDA_Co allows for the timely identification of a reversal in the long-term profitability trend. For Quest Diagnostics (DGX), this growth is driven by high laboratory utilization. The modernization of analyzers without interrupting processes ensures a steady inflow of funds.